A recent survey published in the Journal of the American Medical Association (JAMA) reveals a significant increase in the usage of CBD products. The survey, conducted by NORC at the University of Chicago, indicates a 50% rise in CBD use over the past four years. Approximately one in five respondents reported using CBD within the last year.
Interestingly, the survey also highlights that individuals who use cannabis are more prone to utilizing CBD, CBG, and other hemp-derived compounds. Furthermore, respondents residing in states where marijuana remains illegal demonstrate a higher likelihood of using delta-8 THC—an intoxicating variant of delta-9 THC, the psychoactive compound found in marijuana.
Despite the prevalence of surveys illustrating the growing trend of CBD consumption, there remains a scarcity of comprehensive data regarding the potential benefits and risks associated with these substances. Angela Bryan, a professor at the University of Colorado-Boulder who specializes in the public health consequences of cannabis legalization, emphasizes the dearth of significant research on the effects, both positive and negative, of CBD and related compounds. Although not involved in the JAMA study, Bryan underscores the need for conclusive studies to determine the health implications of these substances.
The popularity of CBD and similar compounds has surged since the enactment of the 2018 farm bill, which legalized hemp production. These compounds can be found in various products such as lotions, tinctures, candies, and vapes. However, due to limited government regulation, individuals should exercise caution when using such products. In fact, the U.S. Food and Drug Administration (FDA) has only approved one drug containing CBD in 2018, specifically for the treatment of two rare seizure disorders.
Surveys indicate that people employ CBD and other hemp-derived compounds to alleviate a myriad of conditions, ranging from anxiety and sleep problems to pain management. However, experts stress the inadequate amount of clinical research available on these substances. The FDA has even issued warnings that CBD can potentially cause liver injury and may interact poorly with certain medications.
Of particular concern is the growing popularity of delta-8 THC, not only due to its adverse side effects but also because of the manner in which it is manufactured. Some states, including Colorado, have implemented regulations or bans on delta-8 THC. Nonetheless, it continues to be sold in numerous regions as a result of a loophole in federal law.
Angela Bryan further underscores the implications of the survey, highlighting that individuals who lack access to legal delta-9 THC may seek out delta-8 THC. Nevertheless, she notes that there is still significantly less information available regarding delta-8 THC compared to its counterpart, delta-9 THC. As the popularity of CBD products continues to rise, it becomes increasingly crucial to conduct further research to ascertain the potential risks and benefits associated with these substances.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.